Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial.
作者信息
Sharretts John, Galescu Ovidiu, Gomatam Shanti, Andraca-Carrera Eugenio, Hampp Christian, Yanoff Lisa
机构信息
From the Food and Drug Administration, Silver Spring, MD.
出版信息
N Engl J Med. 2020 Sep 10;383(11):1000-1002. doi: 10.1056/NEJMp2003873.
PMID:32905671
Abstract
摘要
Zotero 插件